Sexually acquired hepatitis C virus infection: A review

International Journal of Infectious Diseases

Volumn 49, Issue , 2016, Pages 47-58

  Chan, Denise P C ^a   Sun, Hsin Yun ^b   Wong, Horas T H ^c   Lee, Shui Shan ^a   Hung, Chien Ching ^b,d,e  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Combination antiretroviral therapy; Direct acting antivirals; Men who have sex with men; Sex health; Sex network; Sexually transmitted infection; Viral hepatitis

Indexed keywords

ANTIVIRUS AGENT; BIOLOGICAL FACTOR;

ANTIVIRAL THERAPY; EPIDEMIC; EUROPE; HEPATITIS C; HIV SEROSORTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; MEN WHO HAVE SEX WITH MEN; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PATHOGEN CLEARANCE; REVIEW; SCREENING; SEROPREVALENCE; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SOCIAL STIGMA; UNITED STATES; ADULT; GENETICS; HEPACIVIRUS; ISOLATION AND PURIFICATION; MALE; MALE HOMOSEXUALITY; PHYSIOLOGY; PSYCHOLOGY; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VIROLOGY;

ADULT; HEPACIVIRUS; HEPATITIS C; HOMOSEXUALITY, MALE; HUMANS; MALE; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES;

EID: 84975168281     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2016.05.030     Document Type: Review

References (159)

1. Terrault N.A. Sexual activity as a risk factor for hepatitis C. Hepatology 2002, 36(5 Suppl 1):S99-S105.
2. Vandelli C., Renzo F., Romano L., Tisminetzky S., De Palma M., Stroffolini T., et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol 2004, 99:855-859.
3. Tahan V., Karaca C., Yildirim B., Bozbas A., Ozaras R., Demir K., et al. Sexual transmission of HCV between spouses. Am J Gastroenterol 2005, 100:821-824.
4. Terrault N.A., Dodge J.L., Murphy E.L., Tavis J.E., Kiss A., Levin T.R., et al. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology 2013, 57:881-889.
5. Browne R., Asboe D., Gilleece Y., Atkins M., Mandalia S., Gazzard B., et al. Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase?. Sex Transm Infect 2004, 80:326-327.
6. Rauch A., Rickenbach M., Weber R., Hirschel B., Tarr P.E., Bucher H.C., et al. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clin Infect Dis 2005, 41:395-402.
7. Ghosn J., Deveau C., Goujard C., Garrigue I., Saichi N., Galimand J., et al. Increase in hepatitis C virus incidence in HIV-1-infected patients followed up since primary infection. Sex Transm Infect 2006, 82:458-460.
8. van de Laar T.J., van der Bij A.K., Prins M., Bruisten S.M., Brinkman K., Ruys T.A., et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis 2007, 196:230-238.
9. Danta M., Brown D., Bhagani S., Pybus O.G., Sabin C.A., Nelson M., et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 2007, 21:983-991.
10. Obermeier M., Ingiliz P., Weitner L., Cordes C., Moll A., Hintsche B., et al. Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the "real-life setting" proves the concept. Eur J Med Res 2011, 16:237-242.
11. Centers for Disease Control and Prevention (CDC) Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men-New York City, 2005-2010. MMWR Morb Mortal Wkly Rep 2011, 60:945-950.
12. Apers L., Vanden Berghe W., De Wit S., Kabeya K., Callens S., Buyze J., et al. Risk factors for HCV acquisition among HIV-positive MSM in Belgium. J Acquir Immune Defic Syndr 2015, 68:585-593.
13. Urbanus A.T., van de Laar T.J., Geskus R., Vanhommerig J.W., Van Rooijen M.S., Schinkel J., et al. Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010. AIDS 2014, 28:781-790.
14. Dougan S., Balogun M.A., Elford J., Brant L.J., Sinka K., Evans B.G., et al. Can current national surveillance systems in England and Wales monitor sexual transmission of hepatitis C among HIV-infected men who have sex with men?. BMC Public Health 2007, 7:7.
15. Price H., Gilson R., Mercey D., Copas A., Parry J., Nardone A., et al. Hepatitis C in men who have sex with men in London-a community survey. HIV Med 2013, 14:578-580.
16. Raymond H.F., Hughes A., O'Keefe K., Stall R.D., McFarland W. Hepatitis C prevalence among HIV-positive MSM in San Francisco: 2004 and 2008. Sex Transm Dis 2011, 38:219-220.
17. Raymond H.F., Chu P., Nieves-Rivera I., Louie B., McFarland W., Pandori M., et al. Hepatitis C infection among men who have sex with men, San Francisco, 2011. Sex Transm Dis 2012, 39:985-986.
18. Fox J., Nastouli E., Thomson E., Muir D., McClure M., Weber J., et al. Increasing incidence of acute hepatitis C in individuals diagnosed with primary HIV in the United Kingdom. AIDS 2008, 22:666-668.
19. Richardson D., Fisher M., Sabin C.A. Sexual transmission of hepatitis C in MSM may not be confined to those with HIV infection. J Infect Dis 2008, 197:1213-1214.
20. Bottieau E., Apers L., Van Esbroeck M., Vandenbruaene M., Florence E. Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001-2009. Euro Surveill 2010, 15:19673.
21. Apers L., Koole O., Bottieau E., Vandenbruaene M., Ophoff D., Van Esbroeck M., et al. Incidence of HCV and sexually transmitted diseases among HIV positive MSM in Antwerp, Belgium, 2001-2011. Acta Clin Belg 2013, 68:421-426.
22. Wandeler G., Gsponer T., Bregenzer A., Gunthard H.F., Clerc O., Calmy A., et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis 2012, 55:1408-1416.
23. Boesecke C., Grint D., Soriano V., Lundgren J.D., d'Arminio Monforte A., Mitsura V.M., et al. Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?. Liver Int 2015, 35:2384-2391.
24. van der Helm J.J., Prins M., del Amo J., Bucher H.C., Chene G., Dorrucci M., et al. The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS 2011, 25:1083-1091.
25. Witt M.D., Seaberg E.C., Darilay A., Young S., Badri S., Rinaldo C.R., et al. Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011. Clin Infect Dis 2013, 57:77-84.
26. Turner J.M., Rider A.T., Imrie J., Copas A.J., Edwards S.G., Dodds J.P., et al. Behavioural predictors of subsequent hepatitis C diagnosis in a UK clinic sample of HIV positive men who have sex with men. Sex Transm Infect 2006, 82:298-300.
27. Giraudon I., Ruf M., Maguire H., Charlett A., Ncube F., Turner J., et al. Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak?. Sex Transm Infect 2008, 84:111-115.
28. Palacios R., Mata R., Aguilar I., Munoz L., Rios M.J., Vergara S., et al. High seroprevalence but low incidence of HCV infection in a cohort of patients with sexually transmitted HIV in Andalusia, Spain. J Int Assoc Physicians AIDS Care (Chic) 2009, 8:100-105.
29. Barfod T.S., Omland L.H., Katzenstein T.L. Incidence and characteristics of sexually transmitted acute hepatitis C virus infection among HIV-positive men who have sex with men in Copenhagen, Denmark during four years (2006-2009): a retrospective cohort study. Scand J Infect Dis 2011, 43:145-148.
30. Sobrino-Vegas P., Monge Corella S., Serrano-Villar S., Gutierrez F., Blanco J.R., Santos I., et al. Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversions. PLoS One 2014, 9:e116226.
31. Jansen K., Thamm M., Bock C.T., Scheufele R., Kücherer C., Muenstermann D., et al. High prevalence and high incidence of coinfection with hepatitis B, hepatitis C, and syphilis and low rate of effective vaccination against hepatitis B in HIV-positive men who have sex with men with known date of HIV seroconversion in Germany. PLoS One 2015, 10:e0142515.
32. Taylor L.E., Holubar M., Wu K., Bosch R.J., Wyles D.L., Davis J.A., et al. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis 2011, 52:812-818.
33. Garg S., Taylor L.E., Grasso C., Mayer K.H. Prevalent and incident hepatitis C virus infection among HIV-infected men who have sex with men engaged in primary care in a Boston community health center. Clin Infect Dis 2013, 56:1480-1487.
34. Breskin A., Drobnik A., Pathela P., Chan C., Braunstein S., Bornschlegel K., et al. Factors associated with hepatitis C infection among HIV-infected men who have sex with men with no reported injection drug use in New York City, 2000-2010. Sex Transm Dis 2015, 42:382-386.
35. Burchell A.N., Gardner S.L., Mazzulli T., Manno M., Raboud J., Allen V.G., et al. Hepatitis C virus seroconversion among HIV-positive men who have sex with men with no history of injection drug use: results from a clinical HIV cohort. Can J Infect Dis Med Microbiol 2015, 26:17-22.
36. Jin F., Prestage G.P., Matthews G., Zablotska I., Rawstorne P., Kippax S.C., et al. Prevalence, incidence and risk factors for hepatitis C in homosexual men: data from two cohorts of HIV-negative and HIV-positive men in Sydney, Australia. Sex Transm Infect 2010, 86:25-28.
37. Gamage D.G., Read T.R., Bradshaw C.S., Hocking J.S., Howley K., Chen M.Y., et al. Incidence of hepatitis-C among HIV infected men who have sex with men (MSM) attending a sexual health service: a cohort study. BMC Infect Dis 2011, 11:39.
38. Sun H.Y., Chang S.Y., Yang Z.Y., Lu C.L., Wu H., Yeh C.C., et al. Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factors. J Clin Microbiol 2012, 50:781-787.
39. Nishijima T., Shimbo T., Komatsu H., Hamada Y., Gatanaga H., Oka S. Incidence and risk factors for incident hepatitis C infection among men who have sex with men with HIV-1 infection in a large urban HIV clinic in Tokyo. J Acquir Immune Defic Syndr 2014, 65:213-217.
40. Lin A.W., Wong K.H., Chan K. More safer sex intervention needed for HIV-positive MSM with higher education level for prevention of sexually transmitted hepatitis C. J Int AIDS Soc 2014, 17:19663.
41. Yaphe S., Bozinoff N., Kyle R., Shivkumar S., Pai N.P., Klein M. Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review. Sex Transm Infect 2012, 88:558-564.
42. Hagan H., Jordan A.E., Neurer J., Cleland C.M. Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men: a systematic review and meta-analysis. AIDS 2015, 29:2335-2345.
43. Matthews G.V., Hellard M., Kaldor J., Lloyd A., Dore G.J. Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al. AIDS 2007, 21:2112-2113.
44. Matthews G.V., Hellard M., Haber P., Yeung B., Marks P., Baker D., et al. Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis 2009, 48:650-658.
45. Lama J.R., Lucchetti A., Cabezas C., Suarez-Ognio L., Sanchez J. Lack of evidence of hepatitis C and HIV co-infection among men who have sex with men in Peru. Am J Trop Med Hyg 2009, 81:184-186. Peruvian HIV Sentinel Surveillance Working Group.
46. Hammer G.P., Kellogg T.A., McFarland W.C., Wong E., Louie B., Williams I., et al. Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000. Sex Transm Dis 2003, 30:919-924.
47. Alary M., Joly J.R., Vincelette J., Lavoie R., Turmel B., Remis R.S. Lack of evidence of sexual transmission of hepatitis C virus in a prospective cohort study of men who have sex with men. Am J Public Health 2005, 95:502-505.
48. Hao C., Yan H., Yang H., Huan X., Guan W., Xu X., et al. The incidence of syphilis, HIV and HCV and associated factors in a cohort of men who have sex with men in Nanjing, China. Sex Transm Infect 2011, 87:199-201.
49. Tsai J.C., Hung C.C., Chang S.Y., Liu W.C., Wu C.H., Su Y.C., et al. Increasing incidence of recent hepatitis C virus infection among persons seeking voluntary counselling and testing for HIV and sexually transmitted infections in Taiwan. BMJ Open 2015, 5:e008406.
50. Urbanus A.T., van de Laar T.J., Stolte I.G., Schinkel J., Heijman T., Coutinho R.A., et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 2009, 23:F1-F7.
51. Tseng Y.T., Sun H.Y., Chang S.Y., Wu C.H., Liu W.C., Wu P.Y., et al. Seroprevalence of hepatitis virus infection in men who have sex with men aged 18-40 years in Taiwan. J Formos Med Assoc 2012, 111:431-438.
52. Blaxhult A., Samuelson A., Ask R., Hokeberg I. Limited spread of hepatitis C among HIV-negative men who have sex with men in Stockholm, Sweden. Int J STD AIDS 2013, 25:493-495.
53. Schmidt A.J., Falcato L., Zahno B., Burri A., Regenass S., Müllhaupt B., et al. Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?. BMC Public Health 2014, 14:3.
54. McFaul K., Maghlaoui A., Nzuruba M., Farnworth S., Foxton M., Anderson M., et al. Acute hepatitis C infection in HIV-negative men who have sex with men. J Viral Hepat 2015, 22:535-538.
55. Gotz H.M., van Doornum G., Niesters H.G., den Hollander J.G., Thio H.B., de Zwart O. A cluster of acute hepatitis C virus infection among men who have sex with men-results from contact tracing and public health implications. AIDS 2005, 19:969-974.
56. Matser A., Vanhommerig J., Schim van der Loeff M.F., Geskus R.B., de Vries H.J., Prins J.M., et al. HIV-infected men who have sex with men who identify themselves as belonging to subcultures are at increased risk for hepatitis C infection. PLoS One 2013, 8:e57740.
57. Serpaggi J., Chaix M.L., Batisse D., Dupont C., Vallet-Pichard A., Fontaine H., et al. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy. AIDS 2006, 20:233-240.
58. Larsen C, Chaix ML, Le Strat Y, Velter A, Gervais A, Aupérin I, et al. Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG Study. PLoS One 20116:e29322.
59. Sanchez C., Plaza Z., Vispo E., de Mendoza C., Barreiro P., Fernández-Montero J.V., et al. Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain. Liver Int 2013, 33:1357-1362.
60. Vogel M., van de Laar T., Kupfer B., Stellbrink H.J., Kummerle T., Mauss S., et al. Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany. Liver Int 2010, 30:1169-1172.
61. Matthews G.V., Pham S.T., Hellard M., Grebely J., Zhang L., Oon A., et al. Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clin Infect Dis 2011, 52:803-811.
62. Mahony A.A., Donnan E.J., Lester R.A., Doyle J.S., Knox J., Tracy S.L., et al. Beyond injecting drug use: investigation of a Victorian cluster of hepatitis C among HIV-infected men who have sex with men. Med J Aust 2013, 198:210-214.
63. Chan D.P., Lin A.W., Wong K.H., Wong N.S., Lee S.S. Diverse origins of hepatitis C virus in HIV co-infected men who have sex with men in Hong Kong. Virol J 2015, 12:120.
64. van de Laar T., Pybus O., Bruisten S., Brown D., Nelson M., Bhagani S., et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 2009, 136:1609-1617.
65. Fierer D, Khudyakov Y, Hare B. Molecular epidemiology of incident HCV infection in HIV-infected MSM in the US vs infections in Europe and Australia. Abstract number 112. 18th Conference on Retroviruses and Opportunistic Infections, February 27-March 2, 2011, Boston, USA.
66. Ruf M., Cohuet S., Maguire H., Brant L.J., Ramsay M., Lattimore S., et al. Setting up an enhanced surveillance of newly acquired hepatitis C infection in men who have sex with men: a pilot in London and South East region of England. Euro Surveill 2008, 13(47). pii: 19042.
67. European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel. Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) Consensus Conference. AIDS 2011;25:399-409.
68. Benhamou Y., Bochet M., Di Martino V., Charlotte F., Azria F., Coutellier A., et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999, 30:1054-1058.
69. Thomson E.C., Fleming V.M., Main J., Klenerman P., Weber J., Eliahoo J., et al. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut 2011, 60:837-845.
70. Thomson E.C., Nastouli E., Main J., Karayiannis P., Eliahoo J., Muir D., et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009, 23:89-93.
71. Taylor L.E., DeLong A.K., Maynard M.A., Chapman S., Gholam P., Blackard J.T., et al. Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk. AIDS Patient Care STDS 2011, 25:571-577.
72. Freiman J.M., Huang W., White L.F., Geng E.H., Hurt C.B., Taylor L.E., et al. Current practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care. Clin Infect Dis 2014, 59:1686-1693.
73. Danta M., Semmo N., Fabris P., Brown D., Pybus O.G., Sabin C.A., et al. Impact of HIV on host-virus interactions during early hepatitis C virus infection. J Infect Dis 2008, 197:1558-1566.
74. Thomas D.L., Astemborski J., Rai R.M., Anania F.A., Schaeffer M., Galai N., et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000, 284:450-456.
75. Vogel M., Deterding K., Wiegand J., Grüner N.H., Baumgarten A., Jung M.C., et al. Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection. Clin Infect Dis 2009, 49:317-319. author reply 319.
76. Briat A., Dulioust E., Galimand J., Fontaine H., Chaix M.L., Letur-Könirsch H., et al. Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin. AIDS 2005, 19:1827-1835.
77. Operskalski E.A., Kovacs A. HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV/AIDS Rep 2011, 8:12-22.
78. Bruno R., Galastri S., Sacchi P., Cima S., Caligiuri A., DeFranco R., et al. gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut 2010, 59:513-520.
79. Tuyama A.C., Hong F., Saiman Y., Wang C., Ozkok D., Mosoian A., et al. Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology 2010, 52:612-622.
80. Deng A., Chen C., Ishizaka Y., Chen X., Sun B., Yang R. Human immunodeficiency virus type 1 Vpr increases hepatitis C virus RNA replication in cell culture. Virus Res 2014, 184:93-102.
81. Graham C.S., Baden L.R., Yu E., Mrus J.M., Carnie J., Heeren T., et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001, 33:562-569.
82. Joshi D., O'Grady J., Dieterich D., Gazzard B., Agarwal K. Increasing burden of liver disease in patients with HIV infection. Lancet 2011, 377:1198-1209.
83. Bica I., McGovern B., Dhar R., Stone D., McGowan K., Scheib R., et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001, 32:492-497.
84. Bowen D.G., Walker C.M. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005, 436:946-952.
85. Diepolder H.M., Zachoval R., Hoffmann R.M., Wierenga E.A., Santantonio T., Jung M.C., et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995, 346:1006-1007.
86. Gerlach J.T., Diepolder H.M., Jung M.C., Gruener N.H., Schraut W.W., Zachoval R., et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999, 117:933-941.
87. Pelletier S., Drouin C., Bédard N., Khakoo S.I., Bruneau J., Shoukry N.H. Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses. J Hepatol 2010, 53:805-816.
88. Amadei B., Urbani S., Cazaly A., Fisicaro P., Zerbini A., Ahmed P., et al. Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology 2010, 138:1536-1545.
89. Eisenhardt M., Glässner A., Wolter F., Krämer B., Kokordelis P., Nischalke H.D., et al. CD27(+)CD56Bright natural killer cells may be involved in spontaneous clearance of acute hepatitis C in HIV-positive patients. AIDS 2014, 28:1879-1884.
90. Kokordelis P., Krämer B., Körner C., Boesecke C., Voigt E., Ingiliz P., et al. An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients. Hepatology 2014, 59:814-827.
91. Vossen M.T., Matmati M., Hertoghs K.M., Baars P.A., Gent M.R., Leclercq G., et al. CD27 defines phenotypically and functionally different human NK cell subsets. J Immunol 2008, 180:3739-3745.
92. Golden-Mason L., Castelblanco N., O'Farrelly C., Rosen H.R. Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection. J Virol 2007, 81:9292-9298.
93. Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J.C., et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000, 288:339-344.
94. Kim A.Y., Schulze zur Wiesch J., Kuntzen T., Timm J., Kaufmann D.E., Duncan J.E., et al. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med 2006, 3:e492.
95. Thomas D.L., Thio C.L., Martin M.P., Qi Y., Ge D., O'Huigin C., et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009, 461:798-801.
96. Rauch A., Kutalik Z., Descombes P., Cai T., Di Iulio J., Mueller T., et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010, 138:1338-1345. 1345.e1-7.
97. Bradshaw D., Lamoury F., Catlett B., Applegate T.L., McAllister J., Dore G.J., et al. A comparison of seminal hepatitis C virus (HCV) RNA levels during recent and chronic HCV infection in HIV-infected and HIV-uninfected individuals. J Infect Dis 2015, 211:736-743.
98. Taylor L.E., Swan T., Mayer K.H. HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis 2012, 55(Suppl 1):S33-S42.
99. Bradshaw D., Matthews G., Danta M. Sexually transmitted hepatitis C infection: the new epidemic in MSM?. Curr Opin Infect Dis 2013, 26:66-72.
100. Wandeler G., Schlauri M., Jaquier M.E., Rohrbach J., Metzner K.J., Fehr J., et al. Incident hepatitis C virus infections in the Swiss HIV Cohort Study: changes in treatment uptake and outcomes between 1991 and 2013. Open Forum Infect Dis 2015, 2:ofv026.
101. Schmidt A.J., Rockstroh J.K., Vogel M., An der Heiden M., Baillot A., Krznaric I., et al. Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany-a case-control study. PLoS One 2011, 6:e17781.
102. Kippax S., Campbell D., Van de Ven P., Crawford J., Prestage G., Knox S., et al. Cultures of sexual adventurism as markers of HIV seroconversion: a case control study in a cohort of Sydney gay men. AIDS Care 1998, 10:677-688.
103. Ndimbie O.K., Kingsley L.A., Nedjar S., Rinaldo C.R. Hepatitis C virus infection in a male homosexual cohort: risk factor analysis. Genitourin Med 1996, 72:213-216.
104. Clatts M.C., Goldsamt L.A., Yi H. An emerging HIV risk environment: a preliminary epidemiological profile of an MSM POZ Party in New York City. Sex Transm Infect 2005, 81:373-376.
105. Parsons J.T., Schrimshaw E.W., Wolitski R.J., Halkitis P.N., Purcell D.W., Hoff C.C., et al. Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation. AIDS 2005, 19(Suppl 1):S13-S25.
106. Marcus U., Schmidt A.J., Hamouda O. HIV serosorting among HIV-positive men who have sex with men is associated with increased self-reported incidence of bacterial sexually transmissible infections. Sex Health 2011, 8:184-193.
107. Crepaz N., Hart T.A., Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA 2004, 292:224-236.
108. Bourne A., Reid D., Hickson F., Torres-Rueda S., Weatherburn P. Illicit drug use in sexual settings ('chemsex') and HIV/STI transmission risk behaviour among gay men in South London: findings from a qualitative study. Sex Transm Infect 2015, 91:564-568.
109. Bourne A., Reid D., Hickson F., Torres-Rueda S., Steinberg P., Weatherburn P. "Chemsex" and harm reduction need among gay men in South London. Int J Drug Policy 2015, 26:1171-1176.
110. McCall H., Adams N., Mason D., Willis J. What is chemsex and why does it matter?. BMJ 2015, 351:h5790.
111. Hurley M., Prestage G. Intensive sex partying amongst gay men in Sydney. Cult Health Sex 2009, 11:597-610.
112. Lea T., Mao L., Bath N., Prestage G., Zablotska I., de Wit J., et al. Injecting drug use among gay and bisexual men in Sydney: prevalence and associations with sexual risk practices and HIV and hepatitis C infection. AIDS Behav 2013, 17:1344-1351.
113. Zablotska I.B., Crawford J., Imrie J., Prestage G., Jin F., Grulich A., et al. Increases in unprotected anal intercourse with serodiscordant casual partners among HIV-negative gay men in Sydney. AIDS Behav 2009, 13:638-644.
114. Forrest D.W., Metsch L.R., LaLota M., Cardenas G., Beck D.W., Jeanty Y. Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida. J Urban Health 2010, 87:480-485.
115. Kirby T., Thornber-Dunwell M. High-risk drug practices tighten grip on London gay scene. Lancet 2013, 381:101-102.
116. Gilbart V.L., Simms I., Jenkins C., Furegato M., Gobin M., Oliver I., et al. Sex, drugs and smart phone applications: findings from semistructured interviews with men who have sex with men diagnosed with Shigella flexneri 3a in England and Wales. Sex Transm Infect 2015, 91:598-602.
117. Vanhommerig J.W., Lambers F.A., Schinkel J., Geskus R.B., Arends J.E., van de Laar T.J., et al. Risk factors for sexual transmission of hepatitis C virus among human immunodeficiency virus-infected men who have sex with men: a case-control study. Open Forum Infect Dis 2015, 2:ofv115.
118. Landovitz R.J., Tseng C.H., Weissman M., Haymer M., Mendenhall B., Rogers K., et al. Epidemiology, sexual risk behavior, and HIV prevention practices of men who have sex with men using GRINDR in Los Angeles, California. J Urban Health 2013, 90:729-739.
119. Holloway I.W., Pulsipher C.A., Gibbs J., Barman-Adhikari A., Rice E. Network influences on the sexual risk behaviors of gay, bisexual and other men who have sex with men using geosocial networking applications. AIDS Behav 2015, 19(Suppl 2):112-122.
120. Rendina H.J., Jimenez R.H., Grov C., Ventuneac A., Parsons J.T. Patterns of lifetime and recent HIV testing among men who have sex with men in New York City who use Grindr. AIDS Behav 2014, 18:41-49.
121. Bolding G., Davis M., Hart G., Sherr L., Elford J. Gay men who look for sex on the Internet: is there more HIV/STI risk with online partners?. AIDS 2005, 19:961-968.
122. Davis M., Hart G., Bolding G., Sherr L., Elford J. Sex and the Internet: gay men, risk reduction and serostatus. Cult Health Sex 2006, 8:161-174.
123. van de Laar T.J., Matthews G.V., Prins M., Danta M. Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS 2010, 24:1799-1812.
124. Ingiliz P., Krznaric I., Stellbrink H.J., Knecht G., Lutz T., Noah C., et al. Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance. HIV Med 2014, 15:355-361.
125. Bhagani S. Current treatment for chronic hepatitis C virus/HIV-infected individuals: the role of pegylated interferon-alpha and ribavirin. Curr Opin HIV AIDS 2011, 6:483-490.
126. Sulkowski M.S., Naggie S., Lalezari J., Fessel W.J., Mounzer K., Shuhart M., et al. Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection. JAMA 2014, 312:353-361.
127. Molina J.M., Orkin C., Iser D.M., Zamora F.X., Nelson M., Stephan C., et al. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study. Lancet 2015, 385:1098-1106.
128. Sulkowski M., Hezode C., Gerstoft J., Vierling J.M., Mallolas J., Pol S., et al. Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial. Lancet 2015, 385:1087-1097.
129. Rockstroh J.K., Nelson M., Katlama C., Lalezari J., Mallolas J., Bloch M., et al. Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial. Lancet HIV 2015, 2:e319-e327.
130. Osinusi A., Townsend K., Kohli A., Nelson A., Seamon C., Meissner E.G., et al. Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection. JAMA 2015, 313:1232-1239.
131. Naggie S., Cooper C., Saag M., Workowski K., Ruane P., Towner W.J., et al. Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1. N Engl J Med 2015, 373:705-713.
132. Wyles D.L., Ruane P.J., Sulkowski M.S., Dieterich D., Luetkemeyer A., Morgan T.R., et al. Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1. N Engl J Med 2015, 373:714-725.
133. Sulkowski M.S., Eron J.J., Wyles D., Trinh R., Lalezari J., Wang C., et al. Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial. JAMA 2015, 313:1223-1231.
134. Lawitz E., Sulkowski M.S., Ghalib R., Rodriguez-Torres M., Younossi Z.M., Corregidor A., et al. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study. Lancet 2014, 384:1756-1765.
135. Shafran S.D. HIV coinfected have similar SVR rates as HCV monoinfected with DAAs: it's time to end segregation and integrate HIV patients into HCV trials. Clin Infect Dis 2015, 61:1127-1134.
136. El-Sherif O., Khoo S., Solas C. Key drug-drug interactions with direct-acting antiviral in HIV-HCV coinfection. Curr Opin HIV AIDS 2015, 10:348-354.
137. European AIDS Clinical Society (EACS). Part IV HCV treatment options in HCV/HIV co-infected persons. EACS Guidelines version 8. EACS; 2015, p. 72. Available at: (accessed May 20, 2016). http://www.eacsociety.org/files/guidelines_8_0-english_web.pdf.
138. rd Conference on Retroviruses and Opportunistic Infections, February 22-25 2016.
139. rd Conference on Retroviruses and Opportunistic Infections, February 22-25 2016.
140. Naggie S., Marks K.M., Hughes M., Fierer D.S., Kim A.Y., Hollabaugh K., et al. Sofosbuvir plus ribavirin without interferon for treatment of acute hepatitis C virus infection in HIV-1 infected individuals (SWIFT-C). Abstract number 1094. 66th Annual Meeting of the American Association for the Study of Liver Diseases, November 13-17 2015.
141. Martinello M., Gane E.J., Hellard M., Sasadeusz J., Shaw D., Petoumenos K., et al. Sofosbuvir and ribavirin for six weeks is not effective among people with acute and recently acquired HCV infection: the DARE-C II Study. Abstract number 1083. 66th Annual Meeting of the American Association for the Study of Liver Diseases, November 13-17 2015.
142. Fierer D.S., Barbati Z., Dieterich D., Foster A.L., Morey T., Turner S. Sofosbuvir in the treatment of acute HCV infection in HIV-infected men. Abstract number 1090. 66th Annual Meeting of the American Association for the Study of Liver Diseases, November 13-17 2015.
143. Basu P., Shah N.J., John N., Aloysius M., Brown R. Sofosbuvir and ledipasvir versus sofosbuvir and simeprevir combination therapy in the management of acute hepatitis C: a randomized open label prospective clinical pilot study. SLAM C study. Interim data. Abstract number 1074. 66th Annual Meeting of the American Association for the Study of Liver Diseases, November 13-17 2015.
144. Simmons B., Saleem J., Hill A., Riley R.D., Cooke G.S. Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis. Clin Infect Dis 2016, 62:683-694.
145. Workowski K.A., Bolan G.A. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015, 64:1-137.
146. STIs in Gay Men Action Group. Australian STI and HIV testing guidelines 2014 for asymptomatic men who have sex with men. Sydney: STIGMA; 2014. Available at: (accessed February 5, 2016). http://stipu.nsw.gov.au/wp-content/uploads/STIGMA_Testing_Guidelines_Final_v5.pdf.
147. Low E., Vogel M., Rockstroh J., Nelson M. Acute hepatitis C in HIV-positive individuals. AIDS Rev 2008, 10:245-253.
148. Ward C., Lee V. Should we offer routine hepatitis C antibody testing in men who have sex with men?. J Int AIDS Soc 2014, 17(4 Suppl 3):19591.
149. De Ryck I., Berghe V.W., Antonneau C., Colebunders R. Awareness of hepatitis C infection among men who have sex with men in Flanders, Belgium. Acta Clin Belg 2011, 66:46-48.
150. Lambers F.A., Prins M., Davidovich U., Stolte I.G. High awareness of hepatitis C virus (HCV) but limited knowledge of HCV complications among HIV-positive and HIV-negative men who have sex with men. AIDS Care 2014, 26:416-424.
151. Hopwood M., Lea T., Aggleton P. Multiple strategies are required to address the information and support needs of gay and bisexual men with hepatitis C in Australia. J Public Health (Oxf) 2016, 38:156-162.
152. Brener L., Murphy D.A., Cama E.J., Ellard J. Hepatitis C risk factors, attitudes and knowledge among HIV-positive, HIV-negative and HIV-untested gay and bisexual men in Australia. Sex Health 2015, 12:411-417.
153. Ferrand R.A., de Silva S., Cartledge J.D. Tackling STI epidemics through the HIV clinic: is sex high enough on the agenda?. Int J STD AIDS 2008, 19:711-712.
154. Parker R., Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med 2003, 57:13-24.
155. Butt G. Stigma in the context of hepatitis C: concept analysis. J Adv Nurs 2008, 62:712-724.
156. Chesney M.A., Smith A.W. Critical delays in HIV testing and care-the potential role of stigma. Am Behav Sci 1999, 42:1162-1174.
157. Fortenberry J.D., McFarlane M., Bleakley A., Bull S., Fishbein M., Grimley D.M., et al. Relationships of stigma and shame to gonorrhea and HIV screening. Am J Public Health 2002, 92:378-381.
158. Kinsler J.J., Wong M.D., Sayles J.N., Davis C., Cunningham W.E. The effect of perceived stigma from a health care provider on access to care among a low-income HIV-positive population. AIDS Patient Care STDS 2007, 21:584-592.
159. MacCoun R.J. Moral outrage and opposition to harm reduction. Crim Law and Philos 2013, 7:83-98.